Hepatitis C virus.

作者: Christopher Koh , Qisheng Li , Jake Liang

DOI: 10.1128/9781555819439.CH54

关键词:

摘要: Hepatitis C virus (HCV), a member of the genus Hepacivirus in Flaviviridae family, is single-stranded RNA that infects humans and other higher primates has selective tropism to liver. Although HCV particle itself difficult demonstrate, by inferring from virions Flaviviridae, putative composed nucleocapsid core protein viral RNA, surrounded phospholipid membrane which envelope proteins are embedded. The replication cycle can be divided into stages: binding entry cell; polyprotein translation processing; replication; packaging, assembly, release virion. current recommendations for disinfecting reusable endoscopic equipment mechanical washing with detergent soaking 2% glutaraldehyde were shown sufficient eliminate contamination HCV. transmitted vertically mother child. Successful eradication hepatitis antiviral treatment significantly reduces, but does not completely, risk chronic (CHC). Serologic assays detecting infection rapidly developed improved following initial discovery because urgent need screen blood donors prevent transmission. In general, indicated any adult patient CHC who viremic elevated aminotransferases or histologic evidence progressive liver disease, i.e., fibrosis extending beyond portal tracts.

参考文章(349)
Maria Martell, Juan I Esteban, Josep Quer, Joan Genesca, Amy Weiner, Rafael Esteban, Jaume Guardia, Jordi Gomez, Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. Journal of Virology. ,vol. 66, pp. 3225- 3229 ,(1992) , 10.1128/JVI.66.5.3225-3229.1992
J. W. Mosley, E. A. Operskalski, L. H. Tobler, Z. J. Buskell, W. W. Andrews, B. Phelps, J. Dockter, C. Giachetti, L. B. Seeff, M. P. Busch, , The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy Journal of Viral Hepatitis. ,vol. 15, pp. 120- 128 ,(2007) , 10.1111/J.1365-2893.2007.00900.X
S M Feinstone, K B Mihalik, T Kamimura, H J Alter, W T London, R H Purcell, Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infection and Immunity. ,vol. 41, pp. 816- 821 ,(1983) , 10.1128/IAI.41.2.816-821.1983
Thomas D. Schiano, Michael Charlton, Zobair Younossi, Eithan Galun, Timothy Pruett, Ran Tur-Kaspa, Rachel Eren, Shlomo Dagan, Neil Graham, Paulette V. Williams, John Andrews, Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study Liver Transplantation. ,vol. 12, pp. 1381- 1389 ,(2006) , 10.1002/LT.20876
Lucy Golden-Mason, Hugo R. Rosen, Natural killer cells: primary target for hepatitis C virus immune evasion strategies? Liver Transplantation. ,vol. 12, pp. 363- 372 ,(2006) , 10.1002/LT.20708
Sangeeta Jain, Nima Goharkhay, George Saade, Gary Hankins, Garland Anderson, Hepatitis C in Pregnancy American Journal of Perinatology. ,vol. 24, pp. 251- 256 ,(2007) , 10.1055/S-2007-970181
Robert G. Gish, Sanjeev Arora, K. Rajender Reddy, David R. Nelson, Christopher O’Brien, Yi Xu, Brian Murphy, Virological response and safety outcomes in therapy–naïve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study Journal of Hepatology. ,vol. 47, pp. 51- 59 ,(2007) , 10.1016/J.JHEP.2007.02.018
Marcia da Silva Cardoso, Cornelia Lenz, Wibke Hinz, B. Kubanek, Klaus Koerner, Andrea Schwandt, Hepatitis C Virus Stability: The Issue! Vox Sanguinis. ,vol. 76, pp. 124- 127 ,(1999) , 10.1159/000031032
P Cacoub, D Sène, E Rosenthal, S Pol, None, Co-infection par le virus de l’immunodéficience humaine et le virus de l’hépatite C Gastroenterologie Clinique Et Biologique. ,vol. 32, ,(2008) , 10.1016/S0399-8320(08)73270-6